Avadel Pharmaceuticals PLC (AVDL)
17.86
-0.23
(-1.27%)
USD |
NASDAQ |
Apr 24, 14:40
Avadel Pharmaceuticals Enterprise Value: 1.533B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 23, 2024 | 1.533B |
| April 22, 2024 | 1.462B |
| April 19, 2024 | 1.465B |
| April 18, 2024 | 1.469B |
| April 17, 2024 | 1.524B |
| April 16, 2024 | 1.533B |
| April 15, 2024 | 1.435B |
| April 12, 2024 | 1.343B |
| April 11, 2024 | 1.341B |
| April 10, 2024 | 1.358B |
| April 09, 2024 | 1.414B |
| April 08, 2024 | 1.447B |
| April 05, 2024 | 1.407B |
| April 04, 2024 | 1.398B |
| April 03, 2024 | 1.370B |
| April 02, 2024 | 1.381B |
| April 01, 2024 | 1.404B |
| March 28, 2024 | 1.425B |
| March 27, 2024 | 1.420B |
| March 26, 2024 | 1.366B |
| March 25, 2024 | 1.398B |
| March 22, 2024 | 1.455B |
| March 21, 2024 | 1.443B |
| March 20, 2024 | 1.396B |
| March 19, 2024 | 1.326B |
| Date | Value |
|---|---|
| March 18, 2024 | 1.323B |
| March 15, 2024 | 1.337B |
| March 14, 2024 | 1.353B |
| March 13, 2024 | 1.351B |
| March 12, 2024 | 1.341B |
| March 11, 2024 | 1.344B |
| March 08, 2024 | 1.376B |
| March 07, 2024 | 1.347B |
| March 06, 2024 | 1.373B |
| March 05, 2024 | 1.327B |
| March 04, 2024 | 1.356B |
| March 01, 2024 | 1.138B |
| February 29, 2024 | 1.053B |
| February 28, 2024 | 1.032B |
| February 27, 2024 | 1.101B |
| February 26, 2024 | 1.072B |
| February 23, 2024 | 1.029B |
| February 22, 2024 | 1.027B |
| February 21, 2024 | 1.034B |
| February 20, 2024 | 1.050B |
| February 16, 2024 | 1.114B |
| February 15, 2024 | 1.170B |
| February 14, 2024 | 1.175B |
| February 13, 2024 | 1.166B |
| February 12, 2024 | 1.211B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
78.15M
Minimum
Apr 25 2019
1.533B
Maximum
Apr 16 2024
507.97M
Average
410.77M
Median
Feb 10 2021
Enterprise Value Benchmarks
| Trinity Biotech PLC | 118.15M |
| Medtronic PLC | 124.95B |
| Biophytis SA | 2.835M |
| Jazz Pharmaceuticals PLC | 10.93B |
| DBV Technologies SA | -9.690M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -28.79M |
| Revenue (Quarterly) | 19.45M |
| Total Expenses (Quarterly) | 44.35M |
| EPS Diluted (Quarterly) | -0.29 |
| Gross Profit Margin (Quarterly) | 96.44% |
| Profit Margin (Quarterly) | -148.0% |
| Earnings Yield | -11.25% |
| Normalized Earnings Yield | -10.50 |